吸入薬CDMOの世界市場レポート 2024年

吸入薬CDMO市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR6.8％で27億米ドルに成長します。今後予測される成長機会は、精密医療と標的治療への注目、バイオ医薬品吸入療法の急速な拡大、患者中心のソリューションの重視、世界市場の拡大、新市場での新たな機会など、いくつかの要因に起因しています。吸入薬の開発に対する規制当局の支援も一因となっています。この期間に予想される主な動向には、デジタルヘルスソリューションに対する需要の増加、生物学的吸入療法の開発、持続可能な吸入器技術への重点化、人工知能（AI）と機械学習の統合、共同研究やパートナーシップの増加などがあります。

呼吸器疾患の有病率の増加は、吸入薬CDMO市場の成長を促進すると予想されます。呼吸器疾患には、呼吸に関与する器官や構造など、呼吸器系に影響を及ぼすさまざまな病状が含まれます。吸入薬CDMOは、肺への薬剤の処方と送達に関する専門知識を提供することで、これらの疾患に対する製品の開発と製造において重要な役割を果たしています。革新的な吸入療法を開発しようとしている製薬会社に、専門的なインフラ、リソース、知識を提供しています。例えば、オーストラリア保健福祉研究所（Australian Institute of Health and Welfare）の報告によると、オーストラリアにおける呼吸器疾患関連の死亡者数は、2020年の43,031人から2021年には46,551人に増加します。さらに、Lancet誌が発表したデータでは、RSVの新規症例数が2020年の9,972例から2021年には11,255例に増加することが示されており、呼吸器疾患の負担増が強調されています。

吸入薬CDMO業界の主要企業は、専門的な医薬品開発やドラッグデリバリー・サービスを提供するために、戦略的パートナーシップ・アプローチを採用するようになってきています。このようなパートナーシップは、共通の目標を達成するために協力する企業間の長期的で互恵的な取り決めです。例えば、2023年5月、ポルトガルに本拠を置く開発・製造受託機関であるHovione社は、英国に本拠を置く製薬業界向け高精度金属・プラスチック部品メーカーであるH&T Presspart社と提携しました。両社の提携は、プレスパートのサンライズカプセルをベースとしたドライパウダー吸入器のプラットフォームを開発することを目的としており、より高用量のドラッグを供給し、肺へのドラッグデリバリーの効率を向上させるための新技術の創出に重点を置いています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19感染症による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の吸入薬CDMO市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• ドライパウダー吸入器（DPI）
• 定量吸入器（MDI）
• ネブライザー
• ソフトミスト吸入器
• 世界の吸入薬CDMO市場、疾患適応別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 喘息
• 慢性閉塞性肺疾患（COPD）
• 肺動脈高血圧
• 急性呼吸促拍症候群
• 肺線維症
• 世界の吸入薬CDMO市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 手動吸入器（SMI）
• デジタル吸入器
• 世界の吸入薬CDMO市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 大手製薬会社
• 中小規模の製薬会社
• ジェネリック医薬品会社
• その他のエンドユーザー

第7章 地域および国の分析

• 世界の吸入薬CDMO市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の吸入薬CDMO市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 吸入薬CDMO市場の競合情勢
• 吸入薬CDMO市場企業プロファイル
  • Pfizer Inc.
  • Merck KGaA
  • Baxter's BioPharma Solutions
  • Lonza Group AG
  • Catalent Inc.

第31章 その他の主要および革新的な企業

• AptarGroup Inc.
• Samsung Biologics Co. Ltd.
• Siegfried Holding AG
• Recipharm AB
• Stevanato Group SpA
• Cambrex Corporation
• CordenPharma
• Nemera
• Hovione FarmaCiencia SA
• Vectura Group Ltd.
• CARBOGEN AMCIS
• Kindeva Drug Delivery Ltd.
• Frontage Laboratories Inc
• Formosa Laboratories Inc
• Sanner GmbH

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

An inhalation contract development and manufacturing organization (CDMO) is a specialized entity that offers comprehensive services to pharmaceutical and biotechnology firms for the development and production of inhalable drugs. These services are tailored to meet the specific requirements of inhalation products and may include formulation development, analytical testing, process optimization, scale-up, and commercial manufacturing.

The primary products of inhalation CDMOs include dry powder inhalers (DPIs), metered dose inhalers (MDIs), nebulizers, and soft mist inhalers. DPIs are devices used to deliver medication to the lungs in the form of a dry powder and are utilized for various diseases such as asthma, COPD, pulmonary arterial hypertension, acute respiratory distress syndrome, and pulmonary fibrosis. These products are categorized by technology, including manual inhalers and digital inhalers, and are used by a variety of pharmaceutical companies, including large, small, and medium-sized pharmaceutical companies, as well as generic pharmaceutical companies.

The inhalation CDMO market research report is one of a series of new reports from The Business Research Company that provides inhalation CDMO market statistics, including inhalation CDMO industry global market size, regional shares, competitors with an inhalation CDMO market share, detailed inhalation CDMO market segments, market trends and opportunities, and any further data you may need to thrive in the inhalation CDMO industry. This inhalation CDMO market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The inhalation CDMO market size has grown strongly in recent years. It will grow from $1.94 billion in 2023 to $2.08 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to the rising prevalence of respiratory disorders, growing demand for personalized medicine, increasing outsourcing by pharmaceutical companies, and the growth of the biopharmaceutical industry.

The inhalation CDMO market size is expected to see strong growth in the next few years. It will grow to $2.7 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The forecasted growth for the upcoming period can be attributed to several factors, including a focus on precision medicine and targeted therapies, the rapid expansion of biopharmaceutical inhalation therapies, an emphasis on patient-centric solutions, the expansion of the global market, and emerging opportunities in new markets. Regulatory support for the development of inhalation drugs is also a contributing factor. Major trends expected during this period include an increasing demand for digital health solutions, the development of biologic inhalation therapies, a focus on sustainable inhaler technologies, the integration of artificial intelligence (AI) and machine learning, as well as an increase in collaborations and partnerships.

The growing prevalence of respiratory disorders is expected to drive the growth of the inhalation CDMO market. Respiratory disorders encompass a range of medical conditions affecting the respiratory system, including the organs and structures involved in breathing. Inhalation CDMOs play a crucial role in developing and manufacturing products for these disorders by providing expertise in formulating and delivering drugs to the lungs. They offer specialized infrastructure, resources, and knowledge to pharmaceutical companies looking to develop innovative inhalation therapies. For example, reports from the Australian Institute of Health and Welfare indicate an increase in respiratory disease-related deaths in Australia from 43,031 in 2020 to 46,551 in 2021. Additionally, data published by The Lancet shows a rise in new cases of RSV from 9,972 in 2020 to 11,255 in 2021, highlighting the increasing burden of respiratory disorders.

Major companies in the inhalation CDMO industry are increasingly adopting a strategic partnership approach to offer specialized drug development and delivery services. These partnerships are long-term, mutually beneficial arrangements between companies working together to achieve shared goals. For example, in May 2023, Hovione, a Portugal-based Contract Development and Manufacturing Organization, collaborated with H&T Presspart, a UK-based manufacturer of high-precision metal and plastic components for the pharmaceutical industry. Their partnership aims to develop Presspart's Sunrise Capsule-based Dry Powder Inhaler platform, focusing on creating new technologies for delivering higher doses of drugs and improving the efficiency of drug delivery to the lungs.

In June 2022, Kindeva Drug Delivery L.P., a US-based drug delivery and manufacturing company, acquired iPharma Labs, Inc., for an undisclosed sum. This strategic acquisition aimed to bolster Kindeva's presence in the expanding market for inhaled drug delivery technologies. iPharma Labs Inc., based in the US, specializes in providing contract development and manufacturing services for inhaled medicines.

Major companies operating in the inhalation cdmo market report are Pfizer Inc., Merck KGaA, Baxter's BioPharma Solutions, Lonza Group AG, Catalent Inc., AptarGroup Inc., Samsung Biologics Co. Ltd., Siegfried Holding AG, Recipharm AB, Stevanato Group SpA, Cambrex Corporation, CordenPharma, Nemera, Hovione FarmaCiencia SA, Vectura Group Ltd., CARBOGEN AMCIS, Kindeva Drug Delivery Ltd., Frontage Laboratories Inc, Formosa Laboratories Inc, Sanner GmbH, H&T Presspart Ltd., Astech Projects Ltd, Cliantha Research, Dipharma Francis Srl, Copley Scientific.

North America was the largest region in the inhalation contract development and manufacturing organization (CDMO) market in 2023. The regions covered in the inhalation cdmo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the inhalation cdmo market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The inhalation contract development and manufacturing organization (CDMO) market includes revenues earned by providing services such as formulation development, analytical testing, device compatibility testing, process development and optimization, scale-up, and manufacturing. The market value includes the value of related goods sold by the service provider or included within the service offering. The inhalation contract development and manufacturing organization (CDMO) market also includes sales of metered-dose inhalers, dry powder inhalers, and inhalation suspension products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Inhalation CDMO Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on inhalation CDMO market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for inhalation CDMO? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The inhalation CDMO market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Dry Powder Inhaler (DPIs); Metered Dose Inhaler (MDIs); Nebulizer; Soft Mist Inhaler
• 2) By Disease Indication: Asthma; Chronic Obstructive Pulmonary Disease (COPD); Pulmonary Arterial Hypertension; Acute Respiratory Distress Syndrome; Pulmonary Fibrosis
• 3) By Technology: Manual Inhalers (SMI); Digital Inhalers
• 4) By End-User: Big Pharmaceutical Companies; Small and Medium-sized Pharmaceutical Companies; Generic Pharmaceutical Companies; Other End-Users
• Companies Mentioned: Pfizer Inc.; Merck KGaA; Baxter's BioPharma Solutions; Lonza Group AG; Catalent Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Inhalation CDMO Market Characteristics

3. Inhalation CDMO Market Trends And Strategies

4. Inhalation CDMO Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Inhalation CDMO Market Size and Growth

• 5.1. Global Inhalation CDMO Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Inhalation CDMO Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Inhalation CDMO Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Inhalation CDMO Market Segmentation

• 6.1. Global Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Dry Powder Inhaler (DPIs)
• Metered Dose Inhaler (MDIs)
• Nebulizer
• Soft Mist Inhaler
• 6.2. Global Inhalation CDMO Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Pulmonary Arterial Hypertension
• Acute Respiratory Distress Syndrome
• Pulmonary Fibrosis
• 6.3. Global Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Manual Inhalers (SMI)
• Digital Inhalers
• 6.4. Global Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Big Pharmaceutical Companies
• Small and Medium-sized Pharmaceutical Companies
• Generic Pharmaceutical Companies
• Other End-Users

7. Inhalation CDMO Market Regional And Country Analysis

• 7.1. Global Inhalation CDMO Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Inhalation CDMO Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Inhalation CDMO Market

• 8.1. Asia-Pacific Inhalation CDMO Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Inhalation CDMO Market

• 9.1. China Inhalation CDMO Market Overview
• 9.2. China Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Inhalation CDMO Market

• 10.1. India Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Inhalation CDMO Market

• 11.1. Japan Inhalation CDMO Market Overview
• 11.2. Japan Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Inhalation CDMO Market

• 12.1. Australia Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Inhalation CDMO Market

• 13.1. Indonesia Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Inhalation CDMO Market

• 14.1. South Korea Inhalation CDMO Market Overview
• 14.2. South Korea Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Inhalation CDMO Market

• 15.1. Western Europe Inhalation CDMO Market Overview
• 15.2. Western Europe Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Inhalation CDMO Market

• 16.1. UK Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Inhalation CDMO Market

• 17.1. Germany Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Inhalation CDMO Market

• 18.1. France Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Inhalation CDMO Market

• 19.1. Italy Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Inhalation CDMO Market

• 20.1. Spain Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Inhalation CDMO Market

• 21.1. Eastern Europe Inhalation CDMO Market Overview
• 21.2. Eastern Europe Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Inhalation CDMO Market

• 22.1. Russia Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Inhalation CDMO Market

• 23.1. North America Inhalation CDMO Market Overview
• 23.2. North America Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Inhalation CDMO Market

• 24.1. USA Inhalation CDMO Market Overview
• 24.2. USA Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Inhalation CDMO Market

• 25.1. Canada Inhalation CDMO Market Overview
• 25.2. Canada Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Inhalation CDMO Market

• 26.1. South America Inhalation CDMO Market Overview
• 26.2. South America Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Inhalation CDMO Market

• 27.1. Brazil Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Inhalation CDMO Market

• 28.1. Middle East Inhalation CDMO Market Overview
• 28.2. Middle East Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Inhalation CDMO Market

• 29.1. Africa Inhalation CDMO Market Overview
• 29.2. Africa Inhalation CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Inhalation CDMO Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Inhalation CDMO Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Inhalation CDMO Market Competitive Landscape And Company Profiles

• 30.1. Inhalation CDMO Market Competitive Landscape
• 30.2. Inhalation CDMO Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Merck KGaA
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Baxter's BioPharma Solutions
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Lonza Group AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Catalent Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Inhalation CDMO Market Other Major And Innovative Companies

• 31.1. AptarGroup Inc.
• 31.2. Samsung Biologics Co. Ltd.
• 31.3. Siegfried Holding AG
• 31.4. Recipharm AB
• 31.5. Stevanato Group SpA
• 31.6. Cambrex Corporation
• 31.7. CordenPharma
• 31.8. Nemera
• 31.9. Hovione FarmaCiencia SA
• 31.10. Vectura Group Ltd.
• 31.11. CARBOGEN AMCIS
• 31.12. Kindeva Drug Delivery Ltd.
• 31.13. Frontage Laboratories Inc
• 31.14. Formosa Laboratories Inc
• 31.15. Sanner GmbH

32. Global Inhalation CDMO Market Competitive Benchmarking

33. Global Inhalation CDMO Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Inhalation CDMO Market

35. Inhalation CDMO Market Future Outlook and Potential Analysis

• 35.1 Inhalation CDMO Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Inhalation CDMO Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Inhalation CDMO Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer